Edition:
United States

Kulicke and Soffa Industries Inc (KLIC.OQ)

KLIC.OQ on NASDAQ Stock Exchange Global Select Market

17.01USD
20 Jan 2017
Change (% chg)

-- (--)
Prev Close
$17.01
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
106,164
52-wk High
$17.38
52-wk Low
$9.73

KLIC.OQ

Chart for KLIC.OQ

About

Kulicke and Soffa Industries, Inc. designs, manufactures and sells capital equipment and expendable tools, as well as services, maintains, repairs and upgrades equipment, all used to assemble semiconductor devices. The Company supplies a range of bonding equipment. The Company operates through two segments: Equipment and... (more)

Overall

Beta: 1.20
Market Cap(Mil.): $1,205.70
Shares Outstanding(Mil.): 70.88
Dividend: --
Yield (%): --

Financials

  KLIC.OQ Industry Sector
P/E (TTM): 25.58 24.00 19.38
EPS (TTM): 0.66 -- --
ROI: 5.56 12.12 9.57
ROE: 5.98 13.60 9.20

BRIEF-Kulicke and Soffa Industries enters into an agreement with ARC KSFTWPA001 LLC

* Kulicke and Soffa Industries - on Jan. 11 co entered into an agreement for purchase and sale of real property with Arc Ksftwpa001 LLC

Jan 17 2017

BRIEF-Kulicke and Soffa CFO Chou sells 25,000 shares of co's common stock on Nov 23 - sec filing

* Kulicke and Soffa Industries Inc CFO Jonathan Chou reports open market sale of 25,000 shares of co's common stock on nov 23 - SEC filing Source text: (http://bit.ly/2gtk3Vh) Further company coverage:

Nov 25 2016

BRIEF-Kulicke and soffa Industries reports qtrly earnings per share $0.15

* Q4 earnings per share view $0.11, revenue view $140.1 million -- Thomson Reuters I/B/E/S

Nov 15 2016

BRIEF-Kulicke & Soffa appoints Fusen Chen as president and CEO

* Jonathan Chou, chief financial officer and interim CEO, will continue to serve as CFO of company Source text for Eikon: Further company coverage:

Oct 03 2016

BRIEF-Kulicke & Soffa reports Q3 earnings per share $0.45

* Q3 revenue $216.4 million versus i/b/e/s view $200.8 million

Aug 03 2016

BRIEF-Pioneer Pharma (Singapore) Pte buys 1.3 mln shares of Novabay Pharmaceuticals

* Pioneer Pharma (Singapore) Pte. Ltd. reports acquisition of 1.3 mln shares of Novabay Pharmaceuticals Inc's Common Stock at $1.91 Per Share - SEC filing

Aug 02 2016

Competitors

  Price Chg
DISCO CORPORATION (6146.T) ¥14,500 +170.00
SHINKAWA LTD. (6274.T) ¥831 +13.00
ASM Pacific Technology Limited (0522.HK) HK$85.00 -1.85

Earnings vs. Estimates